Alambic Investment Management, L.P. - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 51 filers reported holding ATYR PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q1 2017$78,000
+95.0%
22,200
+20.7%
0.01%
+42.9%
Q4 2016$40,000
-83.2%
18,400
-69.5%
0.01%
-90.9%
Q1 2016$238,000
+25.3%
60,396
+212.3%
0.08%
-32.5%
Q4 2015$190,00019,3380.11%
Other shareholders
ATYR PHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$6,398,0005.64%
EcoR1 Capital, LLC 3,917,972$13,713,0001.54%
Redmile Group, LLC 1,886,792$6,604,0000.29%
Rock Springs Capital Management LP 475,000$1,663,0000.08%
VIKING GLOBAL INVESTORS LP 1,384,300$4,845,0000.03%
Artal Group S.A. 500,000$1,750,0000.03%
Alyeska Investment Group, L.P. 704,524$2,466,0000.02%
Glen Harbor Capital Management LLC 153,238$536,0000.01%
RIVERHEAD CAPITAL MANAGEMENT LLC 79,677$279,0000.01%
Meadow Creek Investment Management LLC 126,196$442,0000.01%
View complete list of ATYR PHARMA INC shareholders